ALMS (ALMS) Stock Price & Analysis
ALMS (ALMS) rose 0.00% to USD 28 as of July 25, 2026 at 03:48 UTC, according to Nexqual real-time market data.
ALMS last closed at USD 28; the session ranged USD 26.94–28.51 on volume of 1,140,587 shares. Market capitalization is —, with a 52-week range of USD 3.75–31.35 (NMS). Source: Nexqual, July 25, 2026 at 03:48 UTC.
Key Statistics (as of July 25, 2026 at 03:48 UTC)
| Price | USD 28 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 28 |
| Open | USD 28 |
| Day Range | USD 26.94 – 28.51 |
| 52-Week Range | USD 3.75 – 31.35 |
| Volume | 1,140,587 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (ALMS)
Nexqual's technical model rates ALMS "BUY" based on 4 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 03:48 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 57.07 (neutral) |
| vs SMA50 | Above (USD 24.51) |
| MACD | 1.11 (positive) |
From ALMS's Latest SEC 10-K Filing (filed 2026-03-19)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MBX | MBX Biosciences, Inc. | USD 62 | ▲ 6.35% |
| MLYS | Mineralys Therapeutics, Inc. | USD 26.71 | ▼ 1.11% |
| ABVX | Abivax SA | USD 125.7 | ▼ 3.11% |
| ERAS | Erasca, Inc. | USD 19.11 | ▼ 2.05% |
| ARTV | Artiva Biotherapeutics, Inc. | USD 10.03 | ▲ 0.1% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:48 UTC. This page is informational and not investment advice.